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ABSTRACT
Genome instability is a characteristic enabling factor
for carcinogenesis. HelQ helicase is a component of
human DNA maintenance systems that prevent or re-
verse genome instability arising during DNA replica-
tion. Here, we provide details of the molecular mech-
anisms that underpin HelQ function––its recruitment
onto ssDNA through interaction with replication pro-
tein A (RPA), and subsequent translocation of HelQ
along ssDNA. We describe for the first time a func-
tional role for the non-catalytic N-terminal region of
HelQ, by identifying and characterizing its PWI-like
domain. We present evidence that this domain of
HelQ mediates interaction with RPA that orchestrates
loading of the helicase domains onto ssDNA. Once
HelQ is loaded onto the ssDNA, ATP-Mg2+ binding
in the catalytic site activates the helicase core and
triggers translocation along ssDNA as a dimer. Fur-
thermore, we identify HelQ-ssDNA interactions that
are critical for the translocation mechanism. Our data
are novel and detailed insights into the mechanisms
of HelQ function relevant for understanding how hu-
man cells avoid genome instability provoking can-
cers, and also how cells can gain resistance to treat-
ments that rely on DNA crosslinking agents.
INTRODUCTION
The Ski2-like family of RNA and DNA helicases includes
the HelQ DNA repair helicase (1). Deletion of the helq gene
(helq) causes genome instability, an enabling factor trig-
gering cancers (2). This is manifest through multiple phe-
notypes caused by loss of HelQ function in human, mouse,
Drosophila and Caenorhabditis elegans: Sensitivity to the
DNA inter-strand crosslinkers (ICLs) mitomycin C (3–5),
nitrogen mustard (6,7) and cisplatin (8), although sensitiv-
ity to mitomycin C was absent from chicken DT4 helq
cells (9); sensitivity to camptothecin (10) that blocks DNA
replication by targeting DNA topoisomerase I; increased
replication fork stalling in the absence of ICLs (5); accu-
mulation of radial chromosomes (3); defects in oocyte (11)
and sperm development (4,5); and defective meiotic DNA
double-strand break repair (12). In human cells, phenotypes
caused by helq were made more severe when additional
deletions were made in Fanconi anaemia genes (5) or in
HROB-MCM8 (8), indicating that HelQ functions in hu-
man DNA repair that is distinct from those systems. How-
ever, similar genetic combinations in worms indicated that
helq is epistatic with fcd-2, encoding FancD2 (6) and ad-
ditionally that helq is epistatic with jmjd-5 that encodes a
histone-modifying enzyme (13).
These genetic problems associated with helq highlight
the role of HelQ helicase as one of the ‘caretakers of
the genome’, defects in which pre-dispose cells to becom-
ing cancerous (14,15). GWAS (Genome-Wide Association
Studies) have identified helq polymorphisms and suscepti-
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bility to cancers of the upper aerodigestive and respiratory
tract and breast (16–18). In U2OS cells cancer phenotypes
are triggered by helq (19), and copy number variations
in helq are associated with ovarian cancers (3,20). In addi-
tion, over-expression of HelQ promotes resistance to treat-
ments for ovarian cancers that are based on use of DNA
crosslinkers (21,22), implicating HelQ levels in cells as po-
tential factor to be overcome in hard-to-treat cancers. Over-
all, genetic analysis of helq and cancer association stud-
ies implicate HelQ helicase in recovery of DNA replication
that is stressed or broken by endogenous or environmental
stresses, arising in ways that are reviewed recently in refer-
ences (23,24).
Human HelQ protein was isolated and characterized as
a ssDNA-dependent adenosine triphosphatase (ATPase)
that translocates DNA with 3′ to 5′ polarity (25). It un-
winds DNA duplexes especially well within forked DNA
substrates and was observed to co-localize with replication
forks that had been blocked by camptothecin treatment,
where it persisted for >8 h (26). DNA replication that is
inactivated by DNA breaks or lesions can be restarted by
homologous recombination with essential roles for DNA
helicases, recently reviewed (27–31), or by ‘skipping’ the
block and re-priming replication downstream of the lesion
(32–34). Generation of ssDNA is prominent during these
events, when new DNA synthesis is halted but DNA un-
winding continues and when ssDNA is utilized for repair
by homologous recombination and for resuming replica-
tion past the lesion or break. The replication protein A
(RPA) in eukaryotic cells is an essential ‘first responder’
to ssDNA arising, see reviews (35,36). This protects DNA
and through dynamic interactions with RPA, and multiple
other proteins RPA controls for subsequent repair processes
(37–39). HelQ and RPA interact in human cells (3,4) and
RPA stimulates HelQ helicase assays in vitro by a mech-
anism unknown, but not through preventing re-annealing
of unwound DNA strands (26). Here, we present new data
identifying that a conserved fold in human HelQ triggers
displacement of RPA from ssDNA, suggesting how HelQ
loads onto ssDNA at stressed replication forks, and re-
vealing why RPA stimulates HelQ helicase activity. Fur-
thermore, we provide new molecular details showing that
when loaded onto ssDNA HelQ is activated by ATP-Mg2+




DNA substrates and details of their chemical modifica-
tions are illustrated in Supplementary Figures S1A and B.
Unmodified DNA oligonucleotides were purchased from
SIGMA with Cy5 label on 5′ ends. Chemically modi-
fied oligonucleotides were purchased from Eurofins (phos-
phonothioate DNA), EuroGenTech (Abasic DNA, formed
as a stable tetrahydrofuran) or IDT (methyl phosphonate
DNA). Unless stated, enzymes for DNA manipulations
were from New England Biolabs (NEB). Forked DNA was
made by annealing to room temperature overnight a 1.2:1
ratio of unlabelled to Cy5-labelled oligonucleotides, after
heating at 95◦C for 10 min. DNA substrates were separated
from unannealed oligonucleotides by gel electrophoresis
through 10% w/v acrylamide Tris.HCl, borate and ethylene-
diaminetetraacetic acid (EDTA) (TBE) gels, followed by ex-
cision of the desired substrate as a gel slice gel and soaking
the slice overnight into Tris.HCl pH 7.5 + 150 mM NaCl to
recover DNA. G4 Quadruplex was formed from a 50mer
oligonucleotide following the method in (40), and was 3′
end-labelled using Aminoallyl-UTP-Cy5 (Jena Bioscience)
incubated with TdT.
Proteins
HelQ and the N-terminal HelQ fragment (N-HelQ) were
over-expressed using the Bac-to-Bac baculovirus expres-
sion system from Gibco BRL in SF9 insect cells, each
with N-terminal (His)6, SUMO and StrepII-Flag tags (25).
SF9 cells were cultured in LONZA Insect Xpress protein-
free culture media with L-glutamine supplemented with
pluronic acid, penicillin-streptomycin and amphotericin B.
HelQ protein over-expression was optimized at 5 l virus
per 1 × 106 SF9 cells for 48 h at 27◦C. The N-terminal re-
gion of HelQ was produced by over-expression of HelQ for
prolonged periods, typically 72 h at 27◦C, resulting in natu-
ral protein degradation and the formation of a stable tagged
HelQ fragment, summarized in Supplementary Figure S2.
This fragment (N-HelQ) comprised HelQ amino acids 1–
240 as verified by mass spectrometry. Biomasses were resus-
pended in lysis buffer (150 mM Tris pH8, 150 mM NaCl,
20 mM imidazole, 10% v/v glycerol) containing COMplete
EDTA free protease inhibitor tablets and stored at −80◦C
until purification.
For purification of full-length HelQ columns and buffers
were chilled to 4◦C before use. Purification of the HelQ pro-
tein into fractions was followed by Coomassie staining of
sodium dodecyl sulphate-polyacrylamide gelelectrophore-
sis (SDS-PAGE) gels. Cell biomass was thawed on ice over
several hours before lysis on ice by sonication at 80% pulsed
for 1 min per 5 ml biomass. Soluble proteins after sonication
were collected by centrifugation at 22 000 rpm in centrifuge
Avanti J-26 XP, rotor JLA 10.500. These were fractionated
by precipitation using 0–50% saturation with solid ammo-
nium sulphate added on ice with gentle agitation, at a rate
of adding that was ∼0.3 g per minute. Precipitated protein
was recovered by centrifugation as before, and resuspended
in 50 mM NaCl, 20 mM Imidazole, 50 mM Tris pH8, 10%
v/v glycerol, 1 mM TCEP to dissolve precipitated proteins.
Solubilized proteins were loaded onto a 5 ml NiCl2 charged
Ni-NTA column equilibrated with NTA-A buffer (20 mM
Tris.HCl pH 8.0, 10% v/v glycerol, 1 M NaCl, 10 mM im-
idazole, COMplete EDTA free protease inhibitor tablet).
HelQ protein eluted from this column at ∼100–200 mM im-
idazole was pooled and dialysed for 3 h at 4◦C into 150 mM
NaCl, 10% v/v glycerol, 50 mM Tris.HCl pH 8.0. Dialysed
HelQ was loaded onto a 5 ml heparin column, washed in
HepA buffer (50 mM Tris.HCl pH 8.0, 10% v/v glycerol,
150 mM NaCl, 1 mM TCEP, COMplete EDTA free pro-
tease inhibitor tablet) and bound HelQ eluted from heparin
in a broad peak between 100–400 mM NaCl. HelQ frac-
tions were dialysed into cold buffer HepA for 3 h and the
protein was next loaded onto a 1 ml anion exchange Q-
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and HelQ eluted in a gradient of increasing NaCl concen-
tration at ∼350–600 mM NaCl. Pooled HelQ protein was
dialysed for 3 h at 4◦C into 30% v/v glycerol, 5 mM dithio-
threitol (DTT), 150 mM NaCl, 50 mM Tris.HCl pH 8.0 and
aliquotted for storage at −20◦C. Protein concentration was
calculated using Bradford’s reagent and a calibration curve
of known concentrations of bovine serum albumin.
Purification of N-HelQ was as described above except
that the heparin column step was not included because N-
HelQ did not bind to it in pilot trials. C-HelQ was expressed
with an N-terminal His-tag in Escherichia coli according
to the same method as was used for N-HelQ and follow-
ing the same purification procedure as described for HelQ.
RPA was purified at the Research complex in Harwell fol-
lowing previously described methods (41), and can be seen
in Supplementary Figure S3.
ATPase assays
ATPase activity was measured using the malachite green
dye assay (42). Reactions of 20 l contained protein mixed
with magnesium and ATP (5 mM each), and ssDNA that
was either strand 1 from fork 2 (25 nM) or M13 (300 ng),
as stated in results. Reactions were at 37◦C for 10 min, con-
cluded by addition of 80 l of detergent-free water and 800
l of dye reagent for 2 min at room temperature, followed
by addition of a 34% aqueous solution of sodium citrate
to allow colour development for a further 30 min. Concen-
tration of liberated phosphate was measured by absorbance
at 660 nm against a zero-protein blank and a calibration
curve of known phosphate concentrations. Dye reagent was
a 3:1 ratio of stock solutions of malachite green: ammonium
molybdate. Malachite green stock was 0.045% (weight to
volume) malachite green in water, and ammonium molyb-
date to 4.2% (w/v) in 4 M HCl.
Protein–DNA binding and unwinding assays
DNA substrates are shown in Supplementary Figure S1.
Electrophoretic mobility shift assays (EMSAs) were all in
1× buffer HB (10 mM Tris pH 7.5, 50 g/ml bovine serum
albumin (BSA) and 5% v/v glycerol) containing fresh DTT
(25 mM). Protein and DNA were incubated at 37◦C for 10
min in 20 l reaction volumes. Reactions were loaded di-
rectly onto 5% w/v acrylamide TBE gels for electrophore-
sis at 150 volts for 2 h in Protean II tanks in 1 × TBE
buffer. In EMSA reactions containing RPA and HelQ,
RPA was pre-incubated with DNA at 37◦C prior to adding
HelQ.
Helicase unwinding assays were in the buffer HB buffer
supplemented with 5 mM magnesium chloride and 5 mM
ATP containing fresh DTT (25 mM). Cy5 labelled DNA
substrate (25 nM) was used with addition of ‘cold-trap’
unlabelled oligonucleotide to 2.5 nM. Helicase reactions
were stopped at the time indicated in results by addition of
buffer STOP comprising 2.5% w/v SDS, 200 M EDTA
and 2 g/l of proteinase K. Reaction products were as-
sessed after electrophoresis through 10% acrylamide TBE
gels. Gels were imaged using FLA-3000 or Typhoon ma-
chine and quantified using ImageJ, GelEval and Prism
software.
Analysis of HelQ by native PAGE
Blue Native PAGE was carried out using 3–12% Bis-Tris
gels, markers and loading buffers bought from Invitrogen
(#BN1001BOX) as described in the manufacturer’s instruc-
tions. Protein was pre-incubated in loading buffer at 37◦C
for 10 min and gel electrophoresis was at ambient tempera-
ture for 60–90 min at 175 volts.
Analysis of HelQ by size exclusion chromatography and
SEC-MALS
Size exclusion chromatography was using a Superdex-200
column in buffer comprising 50 mM Tris–HCl pH 8.0,
150 mM NaCl and 10% v/v glycerol, plus ATP and mag-
nesium as stated in results. HelQ was compared to the
molecular mass standards indicated in Figures 2A and 3C,
bought from GE Healthcare (cat. No. 10196234). Size ex-
clusion chromatography-multi-angle static light scattering
(SEC-MALS) was also using a Superdex-200 column in
the same buffers in a Wyatt Dawn 8+ 1260 Infinity II ma-
chine. Pure HelQ protein (200 l of 2.4 M monomer con-
centration) was applied to the column at a flow rate of 1
ml/min, after pre-incubated of HelQ in buffer for 10 min
at 37◦C. Protein mass was calculated using Wyatt DAWN®
HELEOS® II MALS, using a dn/dc of 0.185. The resulting
chromatograms were analyzed using ASTRA® software,
V.6.1.2.84 (Wyatt Tech Corp). The analyses used three con-
ditions, as described in results. For + ATP-Mg2+ reactions,
standard running buffer was supplemented with 0.2 mM
ATP and 0.2 mM MgCl2 and HelQ was pre-incubated in
5 mM MgCl2 and 5 mM ATP at 37◦C for 10 min. For reac-
tions + ssDNA, HelQ was pre-incubated in standard buffer
+ ATP-Mg2+ and with the addition of 5 M of ssDNA that
was strand-1 from fork-2, detailed in Supplementary Figure
S1.
Measurements of DNA fluorescence anisotropy
Protein–DNA interactions were detected using the
PerkinElmer EnVision benchtop plate reader (2105).
Software used was Wallac EnVision Manager using the FP
Fluorescein Dual filters. The software converted fluores-
cence emission values into mP (fluorescent polarization)
values using the equation mP = 1000 x (S-GXP)/(S+GXP);
Where S and P are the emission filters and G is a factor
to correct for effect of the emission filter transmission
variations. Reactions were set up with 1×HB, 25 mM DTT,
fluorescein labelled fork DNA (to optimized concentration)
and loaded into a 384 Nunc black plate. HelQ protein was
diluted to concentrations indicated in results and added
to the reaction plate to a final volume of 50 l. Readings
were taken at 0, 5, 10 and 15 min at 30◦C, calibrated with a
zero-protein control, and plotted as change in mP against
protein concentration using PRISM.
BamHIEIIIA helicase assays
Helicase activity of HelQ in the presence of BamHIEIIIA
were carried out as for standard helicase assays, but with
pre-incubation of BamHI-EIIIA with the DNA fork at de-
scribed concentrations at ambient temperature for 15 min
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RPA-HelQ protein pull-down assays
Protein pull down assays between HelQ or N-HelQ and
RPA were carried out using streptactin resin to trap
(His)6-strep-tagged N-HelQ/HelQ in a gravity flow 0.2 ml
streptactin-sepharose column (IBA). HelQ and RPA were
pre-incubated in a 1:1 molar ratio on ice for 30 min in buffer
comprising 50 mM Tris pH7.5, 10% v/v glycerol, 25 mM
DTT, 150 mM NaCl and 0.02% v/v Tween 20. Proteins
were applied to streptactin columns equilibrated in the same
buffer at 4◦C, with flow-through samples being collected
and re-applied to the column three times for maximal HelQ
binding. Columns were then washed with three column vol-
umes of equilibration buffer prior to elution of bound HelQ
in three column volumes using the same buffer containing
2.5 mM desthiobiotin. Collected samples were analysed by
SDS-PAGE 8% w/v acrylamide gels.
Analysis of N-HelQ sequence and structure homologies
The amino acid sequence of N-HelQ was confirmed by mass
spectrometry and used to model the tertiary structure of
this region in PHYRE2 (43). Resulting predicted structures
were analysed and superimposed with DALI (44) giving a
structural homology match for Brr2 PWI from PDB acces-
sion: 5DCA. The amino acid sequences corresponding to
the four-helix bundle PWI domain were aligned for multiple
HelQ orthologues and Brr2 helicases using Clustal Omega.
RESULTS
Helicase-active HelQ dimers do not require a large HelQ N-
terminal region
The active state of HelQ when translocating DNA is not
presently known, therefore we compared quaternary struc-
tures of purified apoenzyme human HelQ (Figure 1A, a
141 kDa monomer, including affinity tags) with active HelQ
that is proficient at unwinding a forked DNA substrate
(‘Fork-2’) through ssDNA dependent ATPase activity (Fig-
ure 1B and C). As expected, helicase activity was inactivated
by disruption of the HelQ Walker B motif (HelQD463A, Sup-
plementary Figure S4). The HelQ apoenzyme protein mass
was 598 kDa when measured by SEC-MALS (Figure 1D),
consistent with 600-kDa HelQ apoenzyme described previ-
ously (25), indicating tetrameric HelQ. However, addition
of ATP-Mg2+ resulted in HelQ mass being reduced to 265
kDa in SEC-MALS (Figure 1E), and to 240 kDa on fur-
ther addition of ssDNA (Figure 1F), more consistent with
HelQ dimers. A similar effect of ATP-Mg2+ on HelQ was
apparent using analytical gel filtration (AGF)––the HelQ
apoenzyme eluted close to the column void volume (>669
kDa, peak APO), but its elution volume was substantially
increased when ATP-Mg2+ was included in running buffer
(peak 2), and further when ssDNA was also added (peak 3)
(Figure 2A), indicating a much reduced Stokes radius in the
presence of ATP-Mg2+, in agreement with a substantial de-
crease in the HelQ protein mass measured via SEC-MALS.
The HelQ peak 2 fractions containing ATP-Mg2+ unwound
fork-2 without addition of further ATP-Mg2+, confirming
that HelQ is catalytically active in this form (Figure 2B).
We next investigated if we could isolate a HelQ ‘core’ pro-
tein (C-HelQ), comprising only helicase domains, to com-
pare with full length HelQ, aimed at identifying regions
of HelQ that are needed for its various functions. To gen-
erate C-HelQ we used the 826 amino acids that matched
most strongly with the closest homologue of HelQ, the eu-
ryarchaeal Ski2 helicase Hel308 (25–30% amino acid iden-
tity) (Figure 3A and Supplementary Figure S5). This there-
fore excluded the 274 amino acid N-terminal region of HelQ
that lacks sequence homology to other proteins (Figure 3A)
– properties of that region of HelQ are presented later. We
purified C-HelQ of the correct size (85 kDa) and its identity
was confirmed by mass spectrometry (Figure 3B and Sup-
plementary Table S1). C-HelQ formed a single species in
BN-PAGE that migrated close to the 146 kDa marker (Fig-
ure 3C), and in AGF a single C-HelQ peak was detected
in ATP-Mg2+ and ssDNA that sized to ∼228 KDa (Figure
3C and Supplementary Table S2), compatible with C-HelQ
dimers that bound to fork-2 DNA in EMSAs (Figure 3D).
C-HelQ unwound fork-2 similarly to wild-type protein
(Figure 4A). As expected, C-HelQ helicase activity was in-
activated by the D463A ATPase active site substitution used
for full-length HelQ (Figure 4B), and the amino acid sub-
stitution Y642A also inactivated C-HelQ (Figure 4C)––this
is located in helicase motif IV that is thought to facili-
tate protein conformational flexibility necessary for DNA
translocation in some families of helicases (45). Inactivity
of C-HelQY642A suggests a similar mode of action for DNA
translocation by HelQ. We conclude that the N-terminal re-
gion of HelQ is not required for DNA helicase activity, and
that HelQ activated by ATP forms active dimers. Attempts
to trap ATP-induced functional HelQ dimers by chemical
crosslinking were ineffective––the resulting HelQ protein
was catalytically inactive and unable to bind to DNA (Sup-
plementary Figure S6).
HelQ helicase activity is blocked by a single abasic site, G4
DNA and protein barriers
We next introduced chemical modifications into fork-2 at
single sites and assessed their effects on HelQ and C-HelQ
helicase activity––positions of the chemical modifications
and their chemical structures are detailed in Supplemen-
tary Figure S1. These were designed to provide information
about how HelQ interacts with the overall fork-2 structure
and its DNA backbone and bases. HelQ (160 nM) unwound
60% of fork-2 (25 nM) after 30 min, which was reduced to
7% when a single abasic site was located five nucleotides into
the duplex region of the 3′ to 5′ translocating strand (Figure
5A, fork AP1). To ensure that this fork AP1 can be catalyti-
cally unwound we used E. coli RecQ helicase to fully disso-
ciate it without inhibition from the abasic site (Supplemen-
tary Figure S7A). A single methyl-phosphonate or phos-
phonothioate DNA backbone modification at the same po-
sition was less inhibitory, resulting in 20–25% of fork be-
ing unwound by HelQ (Fork-Me and Fork-S, Figure 5A).
HelQ DNA binding was unaffected by any of the chemical
modifications, summarized for Fork-AP1 that showed the
most severely reduced helicase activity (Figure 5B). HelQ
hydrolysed ATP effectively even when its helicase activity
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Figure 1. HelQ apoenzyme is activated into a dimer by ATP-Mg2+ and ssDNA. (A) Purified His-SUMO-SF-tagged HelQ used in this work (calculated
molecular mass of 141 kDa) shown coomassie stained after 8% acrylamide SDS-PAGE. (B) HelQ (0–100 nM) ATPase activity in the absence of ssDNA
(white circles) and when 25 nM was added (black circles). Reactions were in duplicate, and standard error from the mean is shown. ATPase activity is
reported relative to a no protein control (‘blank’) reaction. (C) HelQ (0–100 nM) helicase activity unwinds fork-2 substrate dependent on 5 mM ATP-Mg2+.
Stars indicate position of the Cy5-DNA end label, and B indicates a boiled reaction to fully dissociate all DNA duplex. (D–F) SEC-MALS measurements
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Figure 2. AGF analysis of HelQ proteins. (A) apoenzyme (peak APO)
compared with HelQ in ATP-Mg2+ (peak 2) and in ATP-Mg-ssDNA
(peak 3), showing progressively slower migration of HelQ through a
Superdex-200 column. Also indicated are the elution volumes for proteins
of known mass as indicated. (B) HelQ-containing fractions from AGF
peak 2 (+ATP-Mg2+) unwound fork-2 DNA without addition of more
ATP-Mg2+ to the reactions, indicating that this is active HelQ.
tional uncoupling observed for other helicases from diverse
families, including RecBC (46), PcrA (47), Has1p (48) and
BLM (49). These data indicate that inhibition of HelQ by
DNA modifications was specific for translocation activity
and was not caused by changes in DNA binding and/or AT-
Pase activities.
The strong inhibitory effect of the abasic site was used
to examine further how HelQ engages to unwind the fork-
2 DNA. For this, we used end-point helicase assays titrat-
ing HelQ at concentrations from five-fold lower to 10-fold
higher than DNA, in which Fork-AP1 was again unwound
poorly (5% of DNA unwound) (Figure 5D). Moving the
abasic site to the equivalent position in the opposite DNA
strand had no inhibitory effect on HelQ (Figures 5D, Fork-
AP2), indicating that HelQ translocates on one ‘tracking’
DNA strand. Positioning the abasic site in the tracking
strand within ssDNA seven nucleotides away from the fork
branchpoint also did not inhibit HelQ (Figures 5D, Fork-
AP3). This suggests that HelQ can load onto the DNA
fork close to the ssDNA-dsDNA branchpoint and does not
translocate across the AP3 abasic site––if it did, we would
expect to observe at least partial inhibition of fork unwind-
ing. We assessed this further, in the knowledge that HelQ
tracks along one strand of the fork with 3′ to 5′ polarity,
by varying the length of 3′ ssDNA available at the branch-
point and measuring helicase unwinding (Figure 6A). As
was expected from a previous study (26), HelQ was inac-
tive at unwinding a substrate lacking any 3′ ssDNA at all,
it unwound only 5% of DNA with 5 nt of 3′ ssDNA (Fork
2.05, Supplementary Figure S1A) despite binding normally
to it (Supplementary Figure S7B), but progressively recov-
ered full unwinding activity (50–60% of DNA unwound)
from 10–20 nt of 3′ssDNA (Forks 2.10–2.20). Therefore, the
presence of DNA fork branchpoint alone is sufficient for
HelQ binding to DNA but is not sufficient for triggering
ssDNA stimulated ATPase and translocation activities. Fi-
nally, DNA unwinding by the core HelQ helicase, C-HelQ,
was also strongly inhibited by Fork-AP1, but not by abasic
sites in Fork-AP2 or AP3 (Figure 6B), further evidence that
HelQ and C-HelQ have the same helicase mechanism that
does not require the 274 amino acid N-terminal region.
We next assessed if HelQ could overcome a range of other
potential barriers to DNA translocation. HelQ unwound
fork-2 modified into an RNA–DNA hybrid in which the 3′
tail was RNA (Supplementary Figure S7C), indicating the
it can translocate RNA as well as DNA. However, HelQ
did not unwind a model G4 DNA substrate (40)––four-
stranded DNA in cells implicated in genome instability and
regulation, reviewed most recently in (50)––that was un-
wound by bacterial RecQ used as a positive control (Fig-
ures 6C). The inability of HelQ to generate force sufficient
to dissociate G4 DNA suggested that it may also be unable
to disrupt a protein–DNA barrier. To test this, we used cat-
alytically inactive BamHIE111A bound to DNA (Kd 2.95 ×
10−11 M (51)) that has been used in previous studies to form
a barrier to DNA unwinding (52,53). We incorporated the
hexanucleotide BamHI binding recognition site into the du-
plex region of a DNA fork (Supplementary Figure S1A)
and observed that 100% of this fork was bound by using
160 nM of BamHIE111A (Supplementary Figure S8). In the
same conditions HelQ helicase activity unwound only 10%
of this DNA substrate compared to 50% when BamHIE111A
was absent (Figure 6D), indicating that HelQ is ineffective
at displacing BamHIE111A. We conclude that the DNA un-
winding, but not ATP hydrolysis, activity of HelQ is espe-
cially sensitive to an abasic site and is unable to displace
DNA barriers but is more tolerant of chemical changes to
the DNA/RNA backbone.
A non-catalytic PWI domain in the HelQ N-terminal region
destabilizes RPA-DNA binding
A 250–300 amino acid N-terminal region (Figure 7A) of
metazoan HelQ proteins is presently of unknown function
and is not needed for DNA binding or translocation by
HelQ (Figures 3 and 4). This region, which we refer to as
N-HelQ, lacks overall sequence homology with other pro-
teins and is predicted to be intrinsically disordered (Supple-
mentary Figure S9). However, searches for potential struc-
tural homologies identified a single strong match between
N-HelQ amino acids 128–237 and the four-helix bundle of
a PWI-fold in the crystal structure of a yeast Ski-2 family
helicase Brr2 (Figure 7A and Supplementary Figure S10)
(54). To investigate this further, we purified human N-HelQ
containing the predicted PWI-fold (amino acids 1–240, 46
kDa including the affinity tags for purification), first as a
fragment of full HelQ that arose during its purification that
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Figure 3. HelQ is catalytically active without the 250–300 amino acid N-terminal region. (A) HelQ domains are indicated. The 300-amino acid human
HelQ N-terminal region is predicted to be a ‘intrinsically disordered protein’ (IDP); the ‘core’ (C-HelQ) helicase (826 amino acids) comprises RecA-like
domains, a winged helix domain (WHD), and a helicase ‘ratchet’ (R). Positions of ATP binding (WA) and ATP hydrolysis (WB) active sites are also
indicated. (B) Shows purified C-HelQ that (C) in AGF and native PAGE of C-HelQ in ATP-Mg2+ gave a single population of protein that was consistent
with dimer or trimeric C-HelQ. Also indicated are the AGF elution volumes for proteins of known mass as indicated. (D) Purified C-HelQ bound to fork-2
DNA (25 nM) to form a stable complex in EMSAs, shown compared with HelQ (both at 40, 80 and 160 nM).
S2), and this information was used to clone the correspond-
ing DNA for over-production and purification of N-HelQ
(Figure 7B). N-HelQ could be purified in large quantities
for analysis by analytical ultra-centrifugation that gave a
mean mass of 40.1 KDa over three conditions (Supplemen-
tary Figure S11A) consistent with it being a monomer.
The PWI-fold of Brr2 and related proteins interacts with
DNA and proteins. N-HelQ did not bind to single-stranded,
duplex or forked DNA in EMSAs or in anisotropy mea-
surements compared with a DNA binding control (Figure
7C and Supplementary Figure S11B). We therefore investi-
gated for protein interactions beginning with RPA, which
interacts with HelQ protein in human cells––the interac-
tion was observed to be with RPA70, the ssDNA binding
subunit of heterotrimeric RPA complex (4,26). We puri-
fied RPA heterotrimer (Supplementary Figure S3) and re-
constituted physical interaction with HelQ in vitro. In the
absence of DNA, the RPA70 subunit co-eluted with affin-
ity immobilized HelQ (Figure 7D), and in the presence of
DNA in EMSAs a pre-formed RPA–DNA complex (Fig-
ure 7E, lanes 2 and 3) was ‘super-shifted’ into a slower mi-
grating complex on addition of HelQ. HelQ did not cause
this effect when added to pre-bound E. coli SSB-DNA
complex (Supplementary Figure S12). Therefore, this estab-
lished two methods for next testing physical interaction of
N-HelQ with RPA in vitro when RPA is either bound to
DNA or not (Figure 7E, lanes 6 and 7). However, substitut-
ing N-HelQ in place of HelQ did not reproduce interaction
with RPA in either scenario, or when using alternative and
potentially more sensitive methods––see ‘Discussion’ sec-
tion. Strikingly though, in EMSAs although no super-shift
of RPA–DNA was observed the N-HelQ protein instead
destabilized RPA–DNA binding, resulting in accumulation
of naked DNA, and despite N-HelQ not binding to DNA
(Figure 7F).
Measurements of this effect showed that although RPA
alone bound 100% of the DNA, 40% of the bound DNA
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Figure 4. C-HelQ is a functioning helicase core enzyme. (A) C-HelQ catal-
ysed unwinding of fork-2 DNA (25 nM) comparably to full length HelQ
(both used at 5, 10, 20, 40, 80 and 160 nM). Reactions were in triplicate,
and standard error from the mean is shown in bars. (B) Helicase unwind-
ing of fork-2 (25 nM) by C-HelQ (0, 20, 40, 60, 120 and 240 nM, B is a
boiled reaction) was inactivated by disruption of the ATPase (WB) active
site (D463A), and (C) C-HelQ (0, 5, 10, 20, 40 and 80 nM) was also in-
activated by the amino acid change Y642A in a motif conserved in Ski2
helicases that is needed for DNA translocation but not ATP hydrolysis.
dition of N-HelQ (Figure 8A). Further evidence that N-
HelQ destabilized RPA–DNA binding was gained by mea-
suring the anisotropy of fork-2 DNA labelled with fluores-
cein. RPA binding to fork-2 gave a dissociation constant
(Kd) of 45.21 nM, which increased to 237 nM on addition
of N-HelQ (Figure 8B), and we have already shown that N-
HelQ alone did not bind to DNA (Figures 7C Supplemen-
tary and S11B). N-HelQ had no effect on DNA binding by
E. coli SSB (Supplementary Figure S13). These data suggest
that N-HelQ triggers displacement of RPA from DNA, by
a mechanism independent of DNA binding by HelQ, which
is therefore likely to be through direct interaction with RPA.
Because the PWI fold of other Ski-2 like helicases mediates
protein interactions we reasoned that the predicted N-HelQ
PWI region of N-HelQ may be required to promote disso-
ciation of the RPA–DNA complexes, and we therefore dis-
rupted it. Despite very low overall sequence conservation
between the predicted human N-HelQ PWI fold (residues
128–237) and Brr2 PWI, a conserved aspartic acid residue
was identified (Asp-142 in human HelQ) that is reportedly
necessary for Brr2 function (Figure 8C) (54). In Brr2 this as-
partic acid orientates outward from the core of the PWI fold
that is stabilized by a nearby phenylalanine residue, which
corresponds to Phe-143 in human HelQ. We therefore puri-
fied N-HelQ with glycine substituted for both Asp-142 and
Phe-143 (N-HelQDF-GG), and additionally a truncated N-
HelQ protein that lacks all predicted PWI residues 128–237
(N-HelQTRUN) (Supplementary Figure S14). Neither pro-
tein was able to liberate free DNA from RPA–DNA com-
plex when measured in comparison to N-HelQ (Figure 8D
and E). Although we could not detect a stable N-HelQ–
RPA interaction, we conclude that the N-terminal region
of HelQ functionally interacts with RPA bound to ssDNA
to displace it, and that this requires a predicted PWI-fold.
This activity of N-HelQ suggests a molecular basis for RPA-
stimulated HelQ helicase activity (Figure 9) that is discussed
below.
DISCUSSION
HelQ helicase is part of systems in human cells that guard
against genetic changes that accumulate as part of carcino-
genesis. HelQ is especially associated with DNA repair at
sites where aberrant ssDNA has accumulated as a result of
blocked replicative helicase or polymerase complexes. In-
volvement of HelQ in overcoming DNA damage that blocks
replication makes it a potential stand-alone helicase target
for improving the efficacy of cancer treatments that rely on
replication blocking agents to kill cancer cells. In this study
we identify that the human HelQ protein comprises a non-
catalytic N-terminal region (N-HelQ) for ssDNA loading
via RPA, and a fully active ‘core’ helicase (C-HelQ) that hy-
drolyses ATP and translocates ssDNA without need for N-
HelQ. This in particular enabled us to interrogate the mech-
anisms for DNA loading and translocation by HelQ, gen-
erating a model shown in Figure 9.
HelQ requires ssDNA binding to trigger ATP-dependent
DNA translocation. Evidence from EMSAs, DNA
anisotropy and targeted mutagenesis showed that N-HelQ
disrupts RPA–DNA binding that we propose enables
loading of HelQ onto ssDNA. The observed effect of
N-HelQ on RPA required Asp-142 and Phe-143, located
within a PWI-like fold detected amongst regions of in-
trinsic protein disorder within N-HelQ. Previous work
showed that RPA stimulates HelQ helicase activity, but
not by RPA preventing re-annealing of unwound DNA
(25,26). Our data are consistent with this––RPA-facilitated
loading of HelQ onto ssDNA would be more effective
for triggering HelQ helicase activity compared to ran-
dom collision of HelQ with ssDNA that is free of RPA.
Targeting and expulsion of RPA-ssDNA by HelQ may
also provide a mechanism in cells for localizing HelQ to
ssDNA that arises at stressed replisomes. We observed
N-HelQ dependent liberation of naked DNA from RPA
binding, which suggests that N-HelQ may not only re-
model the disposition of RPA when bound to DNA but
may even displace it altogether. N-HelQ does not bind to
DNA, and this raises the interesting question; why did
we see no evidence for RPA re-associating with DNA
after displacement? Instead, we observed progressive
accumulation of naked DNA. Therefore N-HelQ seems to
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Figure 5. Insights into the translocation mechanism of HelQ. (A) DNA unwinding by HelQ was compared for unmodified fork-2 and fork-2 containing
chemical modification at a single site, indicated to the right of the graph; an abasic site (AP1), a methyl phosphonate (CH3) and a phosphorothioate (S).
Also shown are representative TBE gels for HelQ unwinding fork-2 compared with fork-AP1, the most effective inhibitor of HelQ. HelQ was used at 0, 5,
10, 20, 40, 80 and 160 nM, and B denotes a boiled reaction to fully dissociate the fork. (B) Representative gels showing that HelQ (0–160 nM) bound to
fork-AP1 similarly to fork-2 in EMSAs, and (C) that the ATPase activity of HelQ at 80 nM was not disrupted when mixed with each of the modified forks
as indicated (25 nM). (D) Fork-2 was further modified with AP-sites in the locations indicated and these were used to measure helicase activity of HelQ.
AP-DNA was inhibitory on when present within the duplex region translocating strand. Reactions were in duplicate, and standard error from the mean is
shown. The panels are from gels showing representative unwinding of the DNA forks (25 nM) that were used to generate the graph. HelQ was used at 10,
20, 40, 80 and 160 nM. The lane labelled ‘B’ is of a boiled reaction to fully dissociate the fork DNA to ssDNA.
during the assay. RPA polypeptide subunits and individual
DNA binding domains within them engage with DNA
dynamically, modulated by post-translational modification
and interaction with other proteins (35,55–58). HelQ
interacts with the RPA70 subunit of the heterotrimer––we
speculate that N-HelQ may disrupt the integrity of the
RPA oligomer and/or DNA binding domains sufficiently
to prevent re-binding of DNA. This would in effect inhibit
RPA activity, preventing it from controlling the pathway
of subsequent DNA repair, instead favouring processes
requiring HelQ.
Using EMSAs and protein–protein co-elution we were
able to reconstitute in vitro the physical interaction be-
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Figure 6. (A) Effect on HelQ helicase activity of varying the length of available 3′ ssDNA at the branchpoint of fork-2 substrate. The graph shows HelQ
(50 nM) unwinding the substrates (25 nM) as a function of time (0–20 min.), in duplicated reactions with standard error from the mean indicated. Two
representative assays are shown as gel panels next to the graph, lanes marked ‘B’ indicate boiled reaction mixtures. (B) Inhibition of C-HelQ (0–300 nM)
helicase activity followed the same pattern as for full-length HelQ when mixed with the DNA forks AP1, AP2 and AP3. Reactions were in triplicate, and
standard error from the mean is shown. (C) G4 quadruplex DNA inhibited HelQ (0–160 nM) helicase activity compared with Escherichia coli RecQ (0–160
nM) used as a positive control. Lane ‘B’ indicates G4 DNA that was boiled to fully dissociate DNA strands. (D) Fork DNA (25 nM) that was 100% bound
by BamHIE111A (160 nM, see also Supplementary Figures S4 and 7) was unwound by HelQ (0–160 nM, white circles) less effectively than unbound fork
(black circles). Representative gels are shown of reactions that were repeated three times, with standard error from the mean shown.
been reported previously in human cells (3,4). However,
these same methods and others––chemical crosslinking, mi-
croscale thermophoresis and isothermal microcalorimetry
(data not shown)––were unsuccessful at detecting physical
interaction of N-HelQ with RPA. This may be because ad-
ditional sites in HelQ located outside of the N-terminal re-
gion stabilize interaction with RPA to the extent that they
are detectable by those methods. In addition, it is possible
that post-translational modifications to N-HelQ may mod-
ulate its function in this respect, in particular if targeted to
the intrinsic disorder detected within N-HelQ. Nevertheless,
the predicted PWI fold in N-HelQ matched closely the PWI
domain in the crystal structure of a yeast spliceosomal Ski-2
like helicase Brr2 (54,59). Although PWI domains are most
widely associated with nucleic acid binding (60–62), the
PWI domain of Brr2, matching N-HelQ, has variations––it
forms the canonical four-helix bundle of PWIs but lacks
the canonical conserved proline, tryptophan and isoleucine
(‘PWI’) residues. The PWI variant of Brr2 does not bind
nucleic acids but instead mediates protein-protein interac-
tions (54,59,63), consistent with lack of DNA binding and
interaction with RPA protein for N-HelQ presented in this
work.
SEC-MALS gave a molecular mass of 250 kDa for heli-
case active HelQ consistent with a protein dimer, compared
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Figure 7. A predicted PWI-like fold in the non-catalytic HelQ N-terminal region destabilizes RPA–DNA complexes. (A) The 300 amino acid N-terminal
region of human HelQ (N-HelQ) lacks sequence homology with other proteins and is predicted to be an IDP. Searches for predicted structural homology
of N-HelQ identified a strong match between N-HelQ residues 128–237 (orange) with a four-helix bundle PWI-fold in crystal structures of RNA helicase
Brr2 (blue). (B) Purified N-HelQ (47 kDa including a His-SUMO tag) did not bind to fork-2 DNA (25 nM) in EMSAs, (C) when used at 0–500 nM
compared to HelQ (0–160 nM). (D) In vitro reconstitution of HelQ-RPA70 physical interaction utilizing streptavidin-tagged HelQ and untagged RPA70,
in the absence of DNA. HelQ input (I, 20 g, lane 1) that bound to affinity beads was eluted (E) using desthiobiotin buffer (lane 3) after washing with
PBS (W, lane 2). RPA70 alone (I, 20 g, lane 4) did not bind to the affinity beads (lanes 4–6) but co-eluted with HelQ that was pre-bound to the beads
(lane 7). (E) Evidence for physical interaction of HelQ with pre-bound heterotrimeric RPA–DNA complex in EMSAs. Fork-2 DNA (25 nM) was bound
by RPA or HelQ (each at either 5 or 20 nM) as indicated, or HelQ was added to pre-bound RPA–DNA complex as indicated, generating a super-shifted
RPA–HelQ complex (lanes 6 and 7). (F) RPA (12 .5 nM) pre-bound 100% of fork-2 (25 nM, lane 3), that was reduced on addition of N-HelQ (0–500 nM)
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Figure 8. Disruption of the N-HelQ PWI-like fold inactivates RPA displacement. (A) N-HelQ dependent displacement of RPA–DNA complex was mea-
sured as total free DNA visible, in triplicate in EMSAs with standard error shown. (B) Effect of RPA on DNA (fork-2) anisotropy, plotted as change in
fluorescent polarization (mP) when mixed with BSA (500 nM, black circles) or N-HelQ (500 nM, white circles). Kd constants were generated in PRISM
using non-linear best fit. (C) Alignment of N-HelQ and Brr2 PWI regions showing a conserved aspartic acid (Asp-142)––sequences shown are Hs, human;
Mm, mouse; Ec, horse; and Sc, yeast Saccharomyces cerevisiae). Superimposition of N-HelQ model with yeast Brr2 crystal strcuture (PDB ID: 5DCA)
highlighting relative positioning of the Asp-142 and Phe-143 of N-HelQ that were targeted for mutagenesis in N-HelQ. (D) Comparison of DNA released
from pre-bound RPA–DNA complex measured in EMSAs for N-HelQ (black circles), N-HelQ mutant D142A/F143A (DF, triangles) and truncated N-
HelQ lacking the PWI region (TRUN, white circles). Assays were in triplicate data and standard error from the mean values are shown as error bars. (E)
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Figure 9. Schematic model for loading and activation of HelQ heli-
case. HelQ apoenzyme in tetrameric form becomes part of the genome
maintenance/DNA repair response to ssDNA arising at stressed forks,
where it interacts with RPA through its N-terminal PWI-like domain. This
disrupts RPA–DNA complexes sufficiently to accommodate HelQ onto
ssDNA––the data suggest that once RPA is evicted from ssDNA by N-
HelQ it is unable to immediately re-assemble on to DNA. RPA–DNA
binding is conformationally dynamic and these dynamics may be influ-
enced by interacting proteins such as HelQ––a recent review article sum-
marizes these ideas (57). Access to ssDNA triggers HelQ ATPase activity
of the core helicase domains in activated dimers. Translocation of HelQ
occurs along one DNA strand with 3′ to 5′ directionality. HelQ helicase ac-
tivity may separate DNA strands to assist with priming replication restart
and may influence homologous recombination through physical interac-
tions it forms with Rad51 paralogue complexes.
In-line with this, the helicase region of the most closely re-
lated human protein to HelQ, Pol helicase-polymerase fu-
sion (encoded by polQ) (64), is tetrameric when crystallized
with a non-hydrolyzable nucleotide (65). Overall sequence
identity between HelQ and the Pol helicase is 10.8%, rising
to 34.0% identity when amino acids from the Pol interac-
tion surfaces are aligned with HelQ, appearing to cluster in
one particular domain of the HelQ helicase monomer (Sup-
plementary Figure S15). HelQ may therefore be available
as inactive tetramers in readiness for rapid deployment as
active dimers when required for replication-coupled DNA
repair. In this scenario we would predict that activation of
HelQ requires disruption or re-arrangement of these ratchet
interfaces to transition from tetramer to dimer. HelQ binds
as a stable complex to DNA in EMSAs in buffer conditions
supporting either apoenzyme HelQ (e.g. Figure 3D) or ac-
tivated dimeric HelQ (Supplementary Figure S16), indicat-
ing that DNA binding alone is unlikely to trigger change in
oligomeric state. Substantial fork unwinding was observed
from a 10 nt 3′ ssDNA overhang but was inactivated by a
5-nt overhang, and HelQ was not inhibited by positioning
of an AP site 7 nt distant from the fork branchpoint (Fig-
ure 5). This indicates the requirement for loading of HelQ
onto at least 6 nt of ssDNA to be effective as a DNA heli-
case and suggests that once loaded translocation is engaged
from close to the branchpoint of this substrate.
HelQ was ineffective at unwinding DNA through phys-
ical barriers or by skipping over a single abasic site in
the DNA tracking strand (Figure 5). Addition of RPA to
these reactions did not improve HelQ DNA unwinding ac-
tivity, either if RPA was pre-incubated with the DNA or
not (Supplementary Figure S17), data that together indi-
cate that HelQ it is unlikely to function as a ‘fork clear-
ance’ protein, unlike other helicases that push through these
barriers (52,66–67). Interaction of HelQ with Rad51 par-
alogue complexes BCDX2 and CX3 (3,4), its disruption of
Rad51 bound to duplex DNA (12) and the lack of change
to crossover recombination frequency when HelQ is lost (4)
suggest that HelQ may be part of the homology-dependent
DNA repair systems functioning via alternative end-joining
(MMEJ/alt-EJ) or DNA annealing (e.g. SDSA) (see re-
views (68,69)), as is proposed for Pol (70,71). Sensitivity
of helq cells to ICLs, and increased replication stalling in
these cells even in the absence of ICLs indicates an impor-
tant role for HelQ in DNA repair coupled to DNA repli-
cation. Proteins of the Fanconi anemia complementation
group are key components for overcoming ICLs and other
replication blocking lesions in human cells, but HelQ seems
to act independently from them. The cellular response to
ICLs is an area of great interest, because ICLs are highly
toxic biproducts of natural cellular chemistry and they are
used in drug therapies against cancerous cells. The protec-
tive effect of HelQ against ICLs in healthy cells is also a fac-
tor promoting resistance to their use as treatments (21,22),
but new knowledge about the molecular mechanisms of
HelQ can be developed into ways of overcoming this prob-
lem, alongside other emerging helicase targets (72).
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